Skip to main content
. 2022 Nov 29;9:1043674. doi: 10.3389/fmed.2022.1043674

TABLE 2.

Outcome analysis.

Variable Total No factor group Factor group P-value
Primary endpoint, n (%) 89 (9.5)
n = 939
24 (6.6)
n = 363
65 (11.3)
n = 576
0.017
Hepatic artery thrombosis, n (%) 52 (5.5)
n = 939
15 (4.1)
n = 363
37 (6.4)
n = 576
0.135
Portal vein thrombosis, n (%) 30 (3.2)
n = 939
6 (1.7)
n = 363
24 (4.2)
n = 576
0.033
Thrombosis of the inferior vena cava, n (%) 16 (1.7)
n = 939
4 (1.1)
n = 363
12 (2.1)
n = 576
0.258
30-day mortality, n (%) 67 (7.1)
n = 939
9 (2.5)
n = 363
58 (10.1)
n = 576
<0.001
Graft failure, n (%) 108 (11.5)
n = 939
20 (5.5)
n = 363
88 (15.3)
n = 576
<0.001
Pulmonary embolism, n (%) 17 (1.8)
n = 939
5 (1.4)
n = 363
12 (2.1)
n = 576
0.429
Myocardial infarction, n (%) 20 (2.1)
n = 939
6 (1.7)
n = 363
14 (2.4)
n = 576
0.422
Stroke, n (%) 7 (0.7)
n = 939
1 (0.3)
n = 363
6 (1.0)
n = 576
0.184
Deep vein thrombosis, n (%) 5 (0.5)
n = 939
1 (0.3)
n = 363
4 (0.7)
n = 576
0.390
Length of intensive care unit stay (d), mean ± SD 9.6 ± 20.2
n = 934
5.9 ± 11.1
n = 361
12.0 ± 23.9
n = 573
<0.001
Length of hospital stay (d), mean ± SD 48.7 ± 40.2
n = 939
38.9 ± 30.3
n = 363
55.0 ± 44.3
n = 576
<0.001
Intraoperative blood loss (ml), mean ± SD 4370.9 ± 4490.7
n = 781
2793.6 ± 2559.4
n = 282
5262.3 ± 5068.0
n = 499
<0.001
Transfused RBC (TU), mean ± SD 9.2 ± 11.3
n = 939
4.2 ± 5.4
n = 363
12.3 ± 12.8
n = 576
<0.001
Transfused PLT (TU), mean ± SD 4.0 ± 5.0
n = 939
1.6 ± 2.3
n = 363
5.5 ± 5.7
n = 576
<0.001
Transfused FFP (TU), mean ± SD 20.22 ± 17.25
n = 939
13.62 ± 10.96
n = 363
24.37 ± 19.11
n = 576
<0.001

Data are presented as absolute number (percentage) or mean ± SD. P-values refer to the comparison between no factor and factor group. Categorial data were compared using the chi-square test. Continuous data were compared using the Mann-Whitney U-test. Bold face indicates p-values < 0.05. SD, standard deviation; RBC, Red blood cells; PLT, Platelet concentrates; FFP, Fresh frozen plasma; TU, Transfusion units.